Clinical Trial Update: Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a networked drug repurposing approach aimed at mechanism-based neuroprotection in acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• REpurposing for Mechanism-based neuroProtection in Acute Ischaemic STROKE

Snippet

Sponsor: Maastricht University | Conditions: Ischemic Stroke, Acute | Phase 2 | Status: UNKNOWN